Decryption – The American laboratory Eli Lilly has already increased by 170 % the price of Mounjaro, its treatment against obesity, in England.
Eli Lilly folds the requirements of Donald Trump. The American laboratory has undertaken to negotiate the sale price of its medicines outside the United States. He has already obtained a 170 % increase in the price of his Mounjaro, indicated in the treatment of diabetes and obesity, in England. In a statement published last week, Eli Lilly says he supports “The objective (stated by Donald Trump, Editor’s note) of a more equitable sharing of the costs of advanced medical research between developed countries».
The American president has been considering for several years that European countries have behaved like clandestine passengers by letting the United States finance most of the medical innovation thanks to the very high prices practiced there. According to the Rand Institute, the price of medicines sold in the United States is indeed three times higher than in Europe – without taking into account the discounts made by laboratories. This, added to the size of the American market …
This article is reserved for subscribers. You have 81% to discover.
Flash sale
€ 4.99 per month for 12 months. Non -binding
Already subscribed? Connect
